Sander A Flaum - Net Worth and Insider Trading

Sander A Flaum Net Worth

The estimated net worth of Sander A Flaum is at least $32,985 dollars as of 2025-06-29. Sander A Flaum is the Director of Eagle Pharmaceuticals Inc and owns about 11,374 shares of Eagle Pharmaceuticals Inc (EGRX) stock worth over $32,985. Details can be seen in Sander A Flaum's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sander A Flaum has not made any transactions after 2018-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Sander A Flaum

To

Sander A Flaum Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sander A Flaum owns 1 companies in total, including Eagle Pharmaceuticals Inc (EGRX) .

Click here to see the complete history of Sander A Flaum’s form 4 insider trades.

Insider Ownership Summary of Sander A Flaum

Ticker Company Transaction Date Type of Owner
EGRX Eagle Pharmaceuticals Inc 2018-03-06 director

Sander A Flaum Latest Holdings Summary

Sander A Flaum currently owns a total of 1 stock. Sander A Flaum owns 11,374 shares of Eagle Pharmaceuticals Inc (EGRX) as of March 6, 2018, with a value of $32,985.

Latest Holdings of Sander A Flaum

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EGRX Eagle Pharmaceuticals Inc 2018-03-06 11,374 2.90 32,985

Holding Weightings of Sander A Flaum


Sander A Flaum Form 4 Trading Tracker

According to the SEC Form 4 filings, Sander A Flaum has made a total of 0 transactions in Eagle Pharmaceuticals Inc (EGRX) over the past 5 years. The most-recent trade in Eagle Pharmaceuticals Inc is the sale of 2,340 shares on March 6, 2018, which brought Sander A Flaum around $126,220.

Insider Trading History of Sander A Flaum

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sander A Flaum Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sander A Flaum Ownership Network

Ownership Network List of Sander A Flaum

No Data

Ownership Network Relation of Sander A Flaum

Insider Network Chart


Sander A Flaum Owned Company Details

What does Eagle Pharmaceuticals Inc do?

Who are the key executives at Eagle Pharmaceuticals Inc?

Sander A Flaum is the director of Eagle Pharmaceuticals Inc. Other key executives at Eagle Pharmaceuticals Inc include director & President and CEO Scott Tarriff , EVP & Chief Commercial Officer Michael Shawn Moran , and Chief Medical Officer Judith Ng-cashin .

Eagle Pharmaceuticals Inc (EGRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eagle Pharmaceuticals Inc (EGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eagle Pharmaceuticals Inc (EGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eagle Pharmaceuticals Inc (EGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eagle Pharmaceuticals Inc Insider Transactions

No Available Data

Sander A Flaum Mailing Address

Above is the net worth, insider trading, and ownership report for Sander A Flaum. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Sander A Flaum's mailing address is: New York Ny 10019.